John Carter, MD, PhD
Fred Hutchinson Cancer Research Center at Seattle Children's Hospital
Identification of novel cdk4/6 effectors in T cell acute lymphoblastic leukemia
Fred Hutchinson Cancer Research Center at Seattle Children's Hospital
Identification of novel cdk4/6 effectors in T cell acute lymphoblastic leukemia
University of Colorado School of Medicine
Targets of the Intrathecal B-Cell Response in Pediatric Opsoclonus-Myoclonus Syndrome
Mayo Clinic
The role of the de-ubiquitinase USP44 in childhood germ cell tumorigenesis
Roswell Park Cancer Institute
Development of anti-tumor molecules targeting the Wilms tumor oncogene, LIN28B
Dana-Farber Cancer Institute
Role of the GAB2-SHP2 network in childhood neuroblastoma pathogenesis
Children's Hospital of Wisconsin, Medical College of Wisconsin
A Phase I/II Trial Evaluating NK Cell Immunotherapy in Relapsed and Refractory Pediatric Solid Tumors
Dana-Farber Cancer Institute
Elucidating epigenetic mechanisms for therapeutic targeting in aggressive pediatric cancers
Lombardi Cancer Center at Georgetown University
Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer
Dana-Farber Cancer Institute
Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling
Children's National Medical Center
Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors
The Children's Hospital at Westmead
Alternative Lengthening of Telomeres in Neuroblastoma
Baylor College of Medicine, Houston TX
Genetic Determinants of Neuropsychological Performance Following Treatment for Pediatric Embryonal Brain Tumors
New York University
University of Hawaii
Dana-Farber Cancer Institute, Harvard
Development of a Material Hardship Intervention
Justus-Liebig-University, Germany
Modification of onconeuronal antigens in the neuroblastoma of paraneoplastic OMS by free RNA